Atheist minister says he had been invited by the founder of the worldwide web Sir Tim to present but had been blocked by BBC senior management
Like this page on Facebook for updates
Friday 20 December 2013
It's been a good year for stock markets. In particular, European and Japanese markets have made large gains. There is a lesson here for all investors: despite a poor economic backdrop, stock markets can perform well. This is often because much of the bad news is priced in and markets are focusing on improved corporate prospects. Similarly, it shows the most uncomfortable investment decisions often turn out to be correct.
Saturday 27 July 2013
Genetics, stem cells and consistent dividends can offset the problems of expiring patents
Friday 05 April 2013
TV pick of the week: Tomorrow's World: A Horizon Special
Tuesday 09 October 2012
AstraZeneca's new boss yesterday agreed his first major deal at the pharmaceuticals giant, spending up to $272m (£169m) on the rights to an experimental kidney drug. This month, on his first day in the job, Pascal Soriot suspended Astra's share buybacks for the rest of the year.
Sunday 29 July 2012
I have heard many experts say that the best days of the pharmaceutical sector are behind it.
Monday 16 July 2012
The Bill and Melinda Gates Foundation has given British scientists a multi-million pound grant to develop GM crops in what could be the most significant PR endorsement for the controversial technology.
Saturday 09 June 2012
The obsessive world of the ground-breaking geneticist is memorably portrayed in an ambitious debut novel that examines what happens when science and human appetites collide.
Thursday 10 May 2012
Britain's biggest drugs firm, GlaxoSmithKline, yesterday stormed ahead with its $2.6bn (£1.6bn) hostile takeover of United States biotech Human Genome Sciences, waving aside the board to take its bid direct to shareholders.
Friday 20 April 2012
GlaxoSmithKline yesterday made a hostile $2.6bn (£1.6bn) bid for Human Genome Sciences (HGS), its long-term partner on treatments including lupus medicine benlysta.
Thursday 22 March 2012
Britain's biggest pharmaceuticals maker, GlaxoSmithKline, has teamed up with Johnson & Johnson and the private equity house Index Ventures to launch a ground-breaking €150m (£125m) fund to discover new drugs.
Thursday 15 March 2012
Free and open access to research, both past and present, is vital to solving global issues
Friday 15 April 2011
Elliott Advisors, the dissident Actelion shareholder which has proposed six independent directors for the Swiss biotech's board, partially welcomed the company's recent nomination of former GlaxoSmithKline boss Jean-Pierre Garnier and ex-Schering-Plough finance chief Robert Bertolini as board members.
Tuesday 08 March 2011
Babies born to women who eat a poor diet during pregnancy are more likely to suffer prematurely from chronic age-related conditions such as type 2 diabetes, say scientists.
Thursday 17 February 2011
The French pharmaceuticals company Sanofi-aventis is to buy the US biotech firm Genzyme Corp in a multibillion-dollar deal it has been pursuing for nine months.
Thursday 10 February 2011
Leading UK neuroscientists today attacked "draconian" funding cuts that could see £4 million stripped from "vital" brain research every year.
Exclusive: 'Putin's Russia has been my biggest regret,' says Nato's outgoing Secretary General
The Osborne Ultimatum: Chancellor’s benefits freeze bombshell will affect ten million households
There’s no excuse for Dave Lee Travis’s behaviour, but we need to keep a sense of proportion
Should gay sex be illegal? 16% of Britons think so
Mark Reckless becomes second Tory MP to defect to Ukip in a month
Benefits 'smart cards' plan revealed by Iain Duncan Smith to stop claimants spending welfare money on alcohol
- 1 Snoop Dogg and Jared Leto buy a stake in Reddit as A-list invests $50m
- 2 Prince held a Facebook Q&A and this is the only question he answered
- 4 Now we know whose fault it is if you end up being murdered in Thailand
- 5 35,000 walrus gather ashore on north-west Alaska beach 'for a rest'